Literature DB >> 31313543

Extremely High Mortality Rates in Patients with Carbapenem-resistant, Hypermucoviscous Klebsiella pneumoniae Blood Stream Infections.

Chaitra Shankar1, Laura Eb Nabarro1, Shalini Anandan1, Raji Ravi1, Priyanka Babu1, Elakkiya Munusamy1, Visali Jeyaseelan2, Priscilla Rupali3, Valsan P Verghese4, Balaji Veeraraghavan5.   

Abstract

BACKGROUND: Infections caused by carbapenem resistant K. pneumoniae are increasing and associated with high mortality rates. There are increasing reports of hypermucoviscous/ hypervirulent K. pneumoniae isolated from various sources. However, there is limited data on the prevalence of hypermucoviscous strains among carbapenem-resistant K. pneumoniae from invasive infections in India and its association with mortality. rmpA, rmpA2 and magA genes are associated with these hypervirulent strains. In this study, we investigate the prevalence of hypermucoviscous strains amongst carbapenem resistant K. pneumoniae isolated from blood culture. Association of mortality rate with meropenem minimum inhibitory concentration and hypermucoviscous strains are determined.
METHODS: 86 non-repetitive carbapenem resistant K. pneumoniae isolated from bacteremia underwent E-test for meropenem minimum inhibitory concentration (MIC) determination and PCR for detection of carbapenamase genes. String test, PCR for rmpA, rmpA2 and magA were performed for characterisation of hypervirulent strains.
Results: 31.3% of the 86 isolates displayed hypermucoviscous phenotype as indicated by a positive string test. Among the two genotypic markers, 7% were positive for rmpA2 and all were negative for rmpA and magA. 74.1% and 67.9% mortality were seen among string test positives and isolates meropenem MIC of ≥16µg/ml respectively (p 0.036 and 0.008 respectively). Isolates with both string positivity and meropenem MIC of ≥16µg/ml had a very high mortality rate of 84.2%.
CONCLUSION: String test, aids prediction of disease severity, and is independently associated with increased mortality in invasive carbapenem resistant K.pneumoniae health care-acquired infections. High meropenem MIC is a significant risk factor for mortality. Combination of string positive carbapenem resistant hypermucoviscous K. pneumoniae resulted in mortality rate of 84.2%. It is important to monitor prevalence of carbapenem resistant hypermucoviscous/hypervirulent K. pneumoniae among invasive isolates especially in a setting with high resistance rates as combination of increased virulence and decreased susceptibility to antimicrobials results in worse outcomes. © Journal of the Association of Physicians of India 2011.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 31313543

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  7 in total

1.  Unusual Hypermucoviscous Clinical Isolate of Klebsiella pneumoniae with No Known Determinants of Hypermucoviscosity.

Authors:  Tamal Dey; Ardhendu Chakrabortty; Aastha Kapoor; Anuja Warrier; Vijaya Lakshmi Nag; Karthikeyan Sivashanmugam; Manoharan Shankar
Journal:  Microbiol Spectr       Date:  2022-06-01

2.  Characterization and Functional Studies of a Novel Depolymerase Against K19-Type Klebsiella pneumoniae.

Authors:  Yunfen Hua; Yongqin Wu; Minjie Guo; Ruijing Ma; Qingchuan Li; Zheyuan Hu; Hongrui Chen; Xingyu Zhang; Hui Li; Qingtian Li; Ping He
Journal:  Front Microbiol       Date:  2022-06-22       Impact factor: 6.064

3.  Emergence of a Hypervirulent Tigecycline-Resistant Klebsiella pneumoniae Strain Co-producing bla NDM-1 and bla KPC-2 With an Uncommon Sequence Type ST464 in Southwestern China.

Authors:  Jingchen Hao; Bangqin Zhang; Jiamin Deng; Yueshuai Wei; Xue Xiao; Jinbo Liu
Journal:  Front Microbiol       Date:  2022-04-29       Impact factor: 6.064

Review 4.  The Glucosinolates: A Sulphur Glucoside Family of Mustard Anti-Tumour and Antimicrobial Phytochemicals of Potential Therapeutic Application.

Authors:  James Melrose
Journal:  Biomedicines       Date:  2019-08-19

5.  Extensive outbreak of colistin resistant, carbapenemase (blaOXA-48, blaNDM) producing Klebsiella pneumoniae in a large tertiary care hospital, India.

Authors:  Swati Sharma; Tuhina Banerjee; Ashok Kumar; Ghanshyam Yadav; Sriparna Basu
Journal:  Antimicrob Resist Infect Control       Date:  2022-01-06       Impact factor: 4.887

6.  Clinical Outcome of Patients on Ceftazidime-Avibactam and Combination Therapy in Carbapenem-resistant Enterobacteriaceae.

Authors:  Vasant Nagvekar; Anand Shah; Vrajeshkumar P Unadkat; Amol Chavan; Ruhi Kohli; Shailendra Hodgar; Aashita Ashpalia; Niranjan Patil; Rahul Kamble
Journal:  Indian J Crit Care Med       Date:  2021-07

7.  Isolation and Characterization of Klebsiella Phages for Phage Therapy.

Authors:  Eleanor M Townsend; Lucy Kelly; Lucy Gannon; George Muscatt; Rhys Dunstan; Slawomir Michniewski; Hari Sapkota; Saija J Kiljunen; Anna Kolsi; Mikael Skurnik; Trevor Lithgow; Andrew D Millard; Eleanor Jameson
Journal:  Phage (New Rochelle)       Date:  2021-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.